Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05842460 · ClinicalTrials.gov registry record · NA
Testing "Ultraprocessed" Front-of-package Label Among Brazilian Consumers
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 1,007
- Enrollment target
NCT05842460: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT05842460 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 1,007 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05842460, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,007 participants
- Enrollment target
Study Summary
The goal of this experiment is to test the effects an "ultraprocessed" warning label on foods and beverages among Brazilian consumers. The main questions it aims to answer are: * Do "ultraprocessed" warnings affect Brazilian consumers' intention to purchase products? * Do "ultraprocessed" warnings affect Brazilian consumers' product perceptions? Participants will see images of four products carrying either nutrient warning labels (which are currently mandatory in Brazil) or nutrient warning labels alongside an experimental warning label informing that the product is ultraprocessed. Participants will then answer survey questions about each product. Researchers will compare responses between both arms to determine if the "ultraprocessed" warning significantly changes the effect of nutrient warnings.
Primary Outcome
How likely the participant would be to buy products will be measured by survey. Response options are on a 1 to 5 scale, with higher scores representing a higher likelihood of buying products.
Interventions
- BEHAVIORAL Nutrient warning labels
- BEHAVIORAL Nutrient and ultraprocessed warning labels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,007 participants |
| Start Date | 2023-05-24 |
| Est. Completion | 2023-06-28 |
| Phase | NA |
What the finished NCT05842460 record still lists
NCT05842460 is an interventional study that assigns participants to a tested intervention. Its 1,007 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower).
The record links to 0 conditions, and to 2 interventions - of which Nutrient warning labels is the first listed.
NCT05842460 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05842460 about?
NCT05842460 is a clinical study titled "Testing "Ultraprocessed" Front-of-package Label Among Brazilian Consumers". The goal of this experiment is to test the effects an "ultraprocessed" warning label on foods and beverages among Brazilian consumers. The main questions it aims to answer are: * Do "ultraprocessed" warnings affect Brazilian consumers' intention to purchase products? * Do "ultraprocessed" warnings ...
What is the current status of trial NCT05842460?
This trial is currently completed. It is a NA study. The enrollment target is 1,007 participants. The study started on 2023-05-24. Estimated completion is 2023-06-28.
What interventions are being tested in trial NCT05842460?
The interventions under investigation include: Nutrient warning labels (BEHAVIORAL), Nutrient and ultraprocessed warning labels (BEHAVIORAL).
Who is sponsoring clinical trial NCT05842460?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05842460's enrollment target sits among peer trials
1,007 106th of 2000 higher than 1,895 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT04389632 · 1,006 participants · Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- NCT06207864 · 1,001 participants · NA
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI